Role of F-box WD Repeat Domain Containing 7 in Type 1 Diabetes

Authors

Sarah W. Mohammed Department of Chemistry, College of Science for Women, University of Baghdad, Al-Jadriya, Baghdad 10001, Iraq.
Zainab M. Qassam Department of Chemistry, College of Science for Women, University of Baghdad, Al-Jadriya, Baghdad 10001, Iraq.
Ekhlass M. Taha Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq.
Nameer M. Salih Alkindi Center for Diabetes and Endocrinology, Welfare Teaching Hospital/Baghdad city.

DOI:

https://doi.org/10.30526/36.3.3030

Keywords:

FBXW7 protein, Newly diagnosis, Type 1 diabetes.

Abstract

Type I diabetes (T1DM) is a chronic immune system disease characterized by the devastation or injury of ß-cells in the Langerhans Island, resulting in insulin deficiency and hyperglycemia. This study determines the new marker F-box and WD repeat domain containing 7 (FBXW7). One hundred twenty type 1 diabetic patients from three different places (central child hospital, Alkindi center for diabetes and endocrinology, Children’s Education Hospital) in Iraq during the period from (20 December 2021 to 25 March 2022) an age ranges of (4-17) years. The patient group consisted of being derived to three groups: group one healthy patient group (33) was included as healthy patient, group two (20) newly diagnosed T1DM and (67) type 1 diabetic with insulin treatment. The quantitative enzyme-linked immunosorbent assay (ELISA) biochemical parameters were used to quantify the protein FBXW-7 levels. FBG, Cholesterol, Triglyceride, HDL, LDL, VLDL, HbA1c, GOT, GPT, Total Oxidant status, and Total Antioxidant status were measured through spectrophotometry. Serum FBXW-7 protein levels were considerably elevated noticeably (p-value = 0.00). In terms of FBXW7 protein, there was a significant variation between the new and therapy groups. There was no significant variation in protein levels between the new compared to healthy groups. Serum FBXW-7 protein was positively correlated with FBG, TG, cholesterol, GOT, GPT, LDL, and VLDL, and was negatively correlated with HDL in the patient group. According to ROC analysis, the cutoff value for FBXW-7 protein was (1.9) in the newly group and (2.1) in the treatment group. Levels of FBXW-7 protein are elevated in DM patients. FBXW-7 protein was significantly different in the treatment group but not different in the newly group when compared with the healthy group.

References

Katsarou, A.; Gudbjörnsdottir, S.; Rawshani, A.; Dabelea, D.; Bonifacio, E.; Anderson, B.J.; Jacobsen, L.M.; Schatz, D.A.; Lernmark, A. Type 1 diabetes mellitus. Nature reviews Disease primers. 2017, 3.1: 1-17.‏ DOI: https://doi.org/10.1038/nrdp.2017.16

Levitsky, L.L.; Misra, M. Complications and screening in children and adolescents with type 1 diabetes mellitus. 2007 Up to date, 17.1.‏

Scott, S.N.; Anderson, L.; Morton, J.P.; Wagenmakers,A.J.M.; Riddell, M.C. Carbohydrate restriction in type 1 diabetes: a realistic therapy for improved glycaemic control and athletic performance?. Nutrients. 2019, 11.5: 1022.‏

Cao, J.; Ge, M.H.; Ling, Z.Q. Fbxw7 tumor suppressor: a vital regulator contributes to human tumorigenesis. Medicine . 2016, 95.7.‏ DOI: https://doi.org/10.1097/MD.0000000000002496

Tejomayee, S. Functionalization of cancer-associated mutant alleles of human CDC4 (FBXW7) PhD[ dissertation], University of British Columbia. 2013.

Li, M.R.; Zhu, C.C.; Ling,T.L.; Zhang, Y.Q.; Xu, J.; Zhao, E.H.; Zhao,G. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma. BMC gastroenterology. 2017, 17.1: 1-8.‏ DOI: https://doi.org/10.1186/s12876-017-0616-7

Welcker, M.; Orian, A.; Grim, J.A.; Eisenman, R.N.; Clurman, B.A. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Current Biology. 2004, 14.20: 1852-1857.‏ DOI: https://doi.org/10.1016/j.cub.2004.09.083

Bae, Y.U.; You, J.H.; Cho, N.H.; Kim, L.E.; Shim,H.M.; Park, J.H.; Cho, H.C. Association of protein Z with prediabetes and type 2 diabetes. Endocrinology and Metabolism . 2021, 36.3: 637.‏

Kyvik, K.O.; Nystrom, L.; Songini, M.; Oestman, J.; Castell, C.; Green, A.; Guyrus, E.; Tirgoviste, C.I.; McKinney, P.A.; Michalkova, D.; Ostrauskas, R.; Raymond, N.T. The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia. 2004, 47.3: 377-384.‏ DOI: https://doi.org/10.1007/s00125-004-1331-9

Ferrara, C. T.; Geyer, S. M.; Liu, Y. F.; Evans-Molina, C.; Libman, I. M.; Besser, R., ... & Type 1 Diabetes TrialNet Study Group. . Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development?. Diabetes care. 2017, 40(5), 698-701.‏ DOI: https://doi.org/10.2337/dc16-2331

World Health Organization. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. World Health Organization, 2011, No. WHO/NMH/CHP/CPM/‏ 11.1

Bruno, V. Lipid disorders in type 1 diabetes. Diabetes & metabolism. 2009, 35.5: 353-360.‏ DOI: https://doi.org/10.1016/j.diabet.2009.04.004

Guarnotta, V.; Vigneri, E.; Pillitteri, G.; Ciresi, A.; Pizzolanti, G.; Giordano, C. Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis. Diabetology & Metabolic Syndrome. 2018, 10.1: 1-8.‏ DOI: https://doi.org/10.1186/s13098-018-0341-6

Qassam, Z.M.; Taha, E.M. Study the Dynamic Thiol -Disulfide Homeostasis in patients with Diabetes type I and type 2. 2022.

Mohammed, S.K.; Taha, E.M.; Muhi, S.A.; A case-control study to determination FBXW7 and Fetuin-A levels in patients with type 2 diabetes in Iraq. Journal of Diabetes & Metabolic Disorders. 2021, 20.1: 237-243.‏

Guo, Y.; Li, J.; Fan, S; Giordano, Q.H. Suppressive role of E3 ubiquitin ligase FBW7 in type I diabetes in non-obese diabetic mice through mediation of ubiquitination of EZH2. Cell death discovery. 2021, 7.1: 1-9.‏